Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | 0.38% | 203.94 | 1.3% | $748.53m | |
| GILD | Gilead Sciences, Inc. | 1.09% | 64.13 | 0.9% | $382.30m | |
| CELG | Celgene Corporation | 0.44% | 95.68 | 1.3% | $342.84m | |
| BIIB | Biogen Inc. | 0.82% | 233.18 | 1.3% | $296.36m | |
| ILMN | Illumina, Inc. | 2.06% | 290.50 | 3.5% | $291.84m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 1.46% | 186.40 | 1.9% | $257.84m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 3.06% | 114.84 | 2.0% | $255.75m | |
| EXAS | Exact Sciences Corporation | -0.19% | 119.23 | 24.1% | $244.03m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.59% | 297.78 | 2.6% | $212.64m | |
| A | Agilent Technologies, Inc. | 1.69% | 72.32 | 1.6% | $201.17m | |
| SRPT | Sarepta Therapeutics, Inc. | -0.56% | 101.50 | 14.7% | $175.52m | |
| INCY | Incyte Corporation | 2.34% | 86.07 | 2.5% | $100.32m | |
| BMRN | BioMarin Pharmaceutical Inc. | 2.24% | 78.22 | 4.3% | $97.40m | |
| GHDX | Genomic Health, Inc. | 0.66% | 74.35 | 1.8% | $87.12m | |
| IONS | Ionis Pharmaceuticals, Inc. | 1.65% | 72.15 | 8.2% | $82.93m |
Company Profile
Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Menlo Park, CA.